SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-016072
Filing Date
2024-04-26
Accepted
2024-04-26 09:00:16
Documents
6
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 865539
2 formdef14a_001.jpg GRAPHIC 11258
3 formdef14a_002.jpg GRAPHIC 49460
4 formdef14a_003.jpg GRAPHIC 33284
5 proxy_001.jpg GRAPHIC 231071
6 proxy_002.jpg GRAPHIC 245293
  Complete submission text file 0001493152-24-016072.txt   1652776
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40652 | Film No.: 24879077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)